KPMG in Precision Medicine

Strategy | Deals | Operations

‹

›

Alasdair Milton, PhD

Managing Director, Healthcare and Life Sciences Strategy, KPMG US

+1 617-988-5419

‹

›

Puja Ghelani

Director Advisory, Strategy - PDT, KPMG US

+1 918-845-2389

‹

›

Kristin C. Pothier

Global and National Leader, HCLS Strategy, KPMG LLP

+1 617 549 2779

In the complex and fast-moving Precision Medicines market clients seek advisors who can provide deep scientific, technical and business insights at a local and global level. Part of the Healthcare and Life Sciences Strategy team, our Precision Medicine practice is a leader in this innovative area of medicine across all therapeutic areas, in markets around the world, with all relevant stakeholders and fueled by experience across the value chain.

Precision Medicine

Navigating innovation in a new normal

The real keys to innovative deal making in Precision Medicine in 2022

Industry leaders Kristin Pothier, KPMG Global Deal Advisory and Strategy Leader for Healthcare and Life Sciences, and Bonnie Anderson, Chairwoman and former CEO of Veracyte, talk about how strategic deals transformed the company and enabled its growth to market leadership. Kristin and Bonnie discuss the end-to-end journey for successful transactions - from strategic planning, through due diligence, integration, and transformation – and offer outlooks for the year ahead.

See us in action

Watch our Precision Medicine leaders talk about the practice and how KPMG is supporting our clients in their deals, and shaping their strategic direction and operations within this innovative industry.

Who we work with

Hospital & Healthcare Systems

Biopharma
Companies

Diagnostic & Life
Science Tools Companies

Commercial, Academic
& Hospital Labs

Private Investors

Our services

Strategy

The foundation of Precision Medicine (PM) has evolved from the simplicity of ‘right patient, right drug, right time’ to now encompass cutting edge sequencing, diagnostic, and therapeutic technologies that are impacting clinical outcomes for patients. We help our clients solve their most complex strategic problems on a G-LOCAL level – global strategic focus and local level execution, leveraging our deep market knowledge, and powered by a proprietary database.

Case study

Defining an organizational and capabilities roadmap for future market leadership for an oncology medical affairs team in a global biopharma client

Case study

Global market assessment of the current and future Precision Medicine landscape to optimize future launch strategies for a global biopharma client

Case study

Developing the go-forward strategy for a leading diagnostics company

Deals

The Precision Medicines deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicines team supports clients across the deal continuum, from front-end ideation and planning, to commercial, financial and operational due diligence, and through integration and separation. Our practice has been on the buy and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.

Case study

Assessing the commercial viability and investment thesis of an early-stage oncology diagnostics company

Case study

Identifying M&A targets for a leading diagnostics company

Case study

Assessing the commercial viability of assets across multiple indications for a royalty rights opportunity

Operations

Operating a high-performing organization in the Precision Medicine space requires enabling capabilities and functions to bridge strategy through execution, to keep pace with regulatory changes and the evolution of technology. KPMG leverages a holistic approach, helping organizations design and align operating models with business strategy, positioning the mid- and back-office functions of Precision Medicine organizations for performance transformation and commercial success.